SUBSCRIBE
SUBSCRIBE

Strand Therapeutics

NEWS
Business
BioSpace Movers & Shakers, Feb. 11
Well into the new year, biopharma and life sciences companies bolster their executive leadership teams and boards with these Movers & Shakers.
February 10, 2022
 · 
9 min read
 · 
Alex Keown
Business
Top Life Sciences Startups to Watch in 2022
BioSpace is proud to present its NextGen Bio “Class of 2022,” a list of up-and-coming life sciences companies in North America that recently launched.
January 4, 2022
 · 
19 min read
 · 
Heather McKenzie
IN THE PRESS
Genetown
Strand Therapeutics Announces First Patient Dosed with Programmable mRNA Therapy STX-001 in Phase 1 Trial for Solid Tumors
May 30, 2024
 · 
3 min read
Drug Development
Strand Therapeutics Receives IND Clearance for Programmable mRNA Therapy STX-001 to Treat Solid Tumors
January 22, 2024
 · 
2 min read
Business
Strand Therapeutics Appoints Colleen Wilson as Chief People Officer
April 24, 2023
 · 
2 min read
Drug Development
Strand Therapeutics Presents Preclinical Data on Programmable mRNA Therapy STX-001 at AACR 2023
April 17, 2023
 · 
2 min read
Genetown
Strand Therapeutics Announces Poster Presentation on STX-001 at the 2023 AACR Annual Meeting
March 14, 2023
 · 
2 min read
Business
Strand Therapeutics Appoints Jay Stella as Chief Business Officer
March 1, 2023
 · 
2 min read
Genetown
Strand Therapeutics Announces Series A1 Bringing Total Round to US$97 Million
November 28, 2022
 · 
5 min read
Genetown
Fierce Biotech names Strand Therapeutics as one of its “Fierce 15” Biotech Companies of 2022
September 12, 2022
 · 
2 min read
Business
Strand Therapeutics Appoints Dr. Prashant Nambiar as Senior Vice President, Research and Translational Development
February 8, 2022
 · 
3 min read
Business
Strand Therapeutics Awarded Phase I NIH SBIR Contract to Develop mRNA-based CAR-T Immunotherapy for Non-Hodgkin’s Lymphoma
November 9, 2021
 · 
3 min read
Load More
AWARDS
  • NextGen Class of 2022
JOBS